Sood AK - Search Results

1

Poor survival with wild-type TP53 ovarian cancer?

Wong KK, Izaguirre DI, Kwan SY, King ER, Deavers MT, Sood AK, Mok SC, Gershenson DM. Wong KK, et al. Among authors: sood ak. Gynecol Oncol. 2013 Sep;130(3):565-9. doi: 10.1016/j.ygyno.2013.06.016. Epub 2013 Jun 22. Gynecol Oncol. 2013. PMID: 23800698 Free PMC article.

2

Paclitaxel and platinum chemotherapy for ovarian carcinoma during pregnancy.

Sood AK, Shahin MS, Sorosky JI. Sood AK, et al. Gynecol Oncol. 2001 Dec;83(3):599-600. doi: 10.1006/gyno.2001.6439. Gynecol Oncol. 2001. PMID: 11733979

3

Ovarian cancer p53 mutation is associated with tumor microvessel density.

Goodheart MJ, Vasef MA, Sood AK, Davis CS, Buller RE. Goodheart MJ, et al. Among authors: sood ak. Gynecol Oncol. 2002 Jul;86(1):85-90. doi: 10.1006/gyno.2002.6730. Gynecol Oncol. 2002. PMID: 12079305

4

The clinical significance of tumor cell-lined vasculature in ovarian carcinoma: implications for anti-vasculogenic therapy.

Sood AK, Fletcher MS, Zahn CM, Gruman LM, Coffin JE, Seftor EA, Hendrix MJ. Sood AK, et al. Cancer Biol Ther. 2002 Nov-Dec;1(6):661-4. doi: 10.4161/cbt.316. Cancer Biol Ther. 2002. PMID: 12642690 Free article.

5

Functional role of matrix metalloproteinases in ovarian tumor cell plasticity.

Sood AK, Fletcher MS, Coffin JE, Yang M, Seftor EA, Gruman LM, Gershenson DM, Hendrix MJ. Sood AK, et al. Am J Obstet Gynecol. 2004 Apr;190(4):899-909. doi: 10.1016/j.ajog.2004.02.011. Am J Obstet Gynecol. 2004. PMID: 15118611

6

EphA2 expression is associated with aggressive features in ovarian carcinoma.

Thaker PH, Deavers M, Celestino J, Thornton A, Fletcher MS, Landen CN, Kinch MS, Kiener PA, Sood AK. Thaker PH, et al. Among authors: sood ak. Clin Cancer Res. 2004 Aug 1;10(15):5145-50. doi: 10.1158/1078-0432.CCR-03-0589. Clin Cancer Res. 2004. PMID: 15297418

7

Biological significance of focal adhesion kinase in ovarian cancer: role in migration and invasion.

Sood AK, Coffin JE, Schneider GB, Fletcher MS, DeYoung BR, Gruman LM, Gershenson DM, Schaller MD, Hendrix MJ. Sood AK, et al. Am J Pathol. 2004 Oct;165(4):1087-95. doi: 10.1016/S0002-9440(10)63370-6. Am J Pathol. 2004. PMID: 15466376 Free PMC article.

8

Malignant mixed mullerian tumor (MMMT) of the cervix.

Sharma NK, Sorosky JI, Bender D, Fletcher MS, Sood AK. Sharma NK, et al. Among authors: sood ak. Gynecol Oncol. 2005 May;97(2):442-5. doi: 10.1016/j.ygyno.2005.01.022. Gynecol Oncol. 2005. PMID: 15863143 Review.

9

Fifth International Conference on Ovarian Cancer: challenges and opportunities.

Sood AK, Abu-Rustum NR, Barakat RR, Bodurka DC, Brown J, Donato ML, Poynor EA, Wolf JK, Gershenson DM. Sood AK, et al. Gynecol Oncol. 2005 Jun;97(3):916-23. doi: 10.1016/j.ygyno.2005.03.013. Gynecol Oncol. 2005. PMID: 15907981

10

Selected highlights from the 5th International Conference on Ovarian Cancer. Houston, TX, USA, 1-4 December 2004.

Sood AK, Coleman RL, Wolf JK, Gershenson DM. Sood AK, et al. Expert Opin Pharmacother. 2005 Jun;6(7):1269-75. doi: 10.1517/14656566.6.7.1269. Expert Opin Pharmacother. 2005. PMID: 15957979 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,164 results

Search Page

Filters